GlassScriptPhysician profile
Jamie Sullivan
NPI 1407353717
$1,460.21
in general payments reported to CMS, 2019-2025
13 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $172 · 2023: $400 · 2024: $552 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.23 |
| Education | $106.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $483.74 | 2022-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $166.77 | 2023-2024 | Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $162.15 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $132.01 | 2021-2025 | Ingrezza |
| Indivior INC. | $112.17 | 2021-2025 | Sublocade |
| Braeburn INC. | $109.77 | 2024 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $86.71 | 2021-2023 | |
| Corium, LLC | $44.80 | 2023 | Azstarys |
| Alkermes, INC. | $43.10 | 2021-2023 | Vivitrol |
| Novo Nordisk INC | $40.73 | 2023-2024 | Wegovy |
| Sage Therapeutics, LLC | $40.51 | 2024-2025 | Zurzuvae |
| Vanda Pharmaceuticals INC. | $22.00 | 2024 | Fanapt |
| Lundbeck LLC | $15.75 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.